Inactive Instrument

Press Releases Catabasis Pharmaceuticals Inc Nasdaq

Equities

US14875P1075

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Astria Therapeutics : - 2024 Proxy Statement	Apr. 22	PU
Astria Therapeutics : - 2023 Annual Report	Apr. 22	PU
Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors	Apr. 09	BU
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)	Apr. 04	AQ
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Apr. 03	BU
Astria Therapeutics : Material Event - Form 8-K	Mar. 25	PU
Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAE	Mar. 25	BU
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)	Mar. 06	AQ
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Mar. 05	BU
Astria Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update	Mar. 04	BU
Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma and Immunology Annual Meeting	Feb. 21	AQ
Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma & Immunology Annual Meeting	Feb. 20	BU
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)	Feb. 06	AQ
Astria Therapeutics to Present at Upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference	Feb. 06	BU
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Feb. 05	BU
Astria Therapeutics Announces Pricing of $125 Million Underwritten Offering	Jan. 30	BU
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)	Dec. 05	AQ
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Dec. 04	BU
Astria Therapeutics to Present STAR-0215 Data at the 2023 World Allergy Congress	Nov. 27	BU
Astria Therapeutics to Present at Upcoming 6th Annual Evercore ISI HealthCONx Conference	Nov. 21	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Catabasis Pharmaceuticals Inc Nasdaq

Equities

US14875P1075

Press Releases

Filters